Rance M J, Ruddock J C, Pacey M S, Cullen W P, Huang L H, Jefferson M T, Whipple E B, Maeda H, Tone J
Central Research Division, Pfizer Limited, Kent, England.
J Antibiot (Tokyo). 1989 Feb;42(2):206-17. doi: 10.7164/antibiotics.42.206.
UK-63,052 complex, a new group of quinomycin-like antibiotics comprising UK-63,052 (factor A), UK-63,598 (factor C), UK-65,662 (factor B) and several uncharacterised minor components, is produced by a new subspecies of the genus Streptomyces for which the name Streptomyces braegensis Dietz subsp. japonicus, is proposed. The strain, N617-29, is characterised by a negative melanin reaction, grey aerial mycelium, spiral spore chains and smooth or slightly warty spores. Structure determination has identified UK-63,052, C56H68N10O14S2, UK-63,598, C53H62N10O14S2 and UK-65,662, C55H66N10O14S2 as quinaldic acid substituted quinomycins with unusual bridgehead sulfur substitution as shown in Fig. 3.
UK-63,052复合物是一组新的类醌霉素抗生素,包括UK-63,052(因子A)、UK-63,598(因子C)、UK-65,662(因子B)以及几种未鉴定的次要成分,由链霉菌属的一个新亚种产生,为此提出了名为日本布雷格链霉菌(Streptomyces braegensis Dietz subsp. japonicus)的名称。该菌株N617-29的特征为黑色素反应阴性、灰色气生菌丝体、螺旋形孢子链以及光滑或稍有疣状的孢子。结构测定已确定UK-63,052(C56H68N10O14S2)、UK-63,598(C53H62N10O14S2)和UK-65,662(C55H66N10O14S2)为喹哪啶酸取代的醌霉素,具有如图3所示的不寻常桥头硫取代。